ORLANDO — AI can transform how dermatologists diagnose skin conditions including melanoma; however, without attention to equitability, specifically in skin of color, it could exacerbate disparities in care, according to a speaker here.
2025
Adewole Adamson, MD, MPP: Addressing Melanoma Diagnosis and Overdiagnosis
Adewole (Ade) Adamson, MD, MPP, FAAD, assistant professor in the Department of Dermatology at Dell Medical School, University of Texas at Austin, presented a session titled, “Approach to Melanoma Diagnosis" at the 2025 American Academy of Dermatology (AAD) Annual Meeting.
Are we done with tanning?
A year ago professors Georgina Long AO and Richard Scolyer AO from the Melanoma Institute Australia were named joint Australians of the Year so, one year on, just how far have we in changing attitudes to tanning and preventing one of the most preventable cancers?
Dr Akkooi on Pathologic Review Discrepancies and Overtreatment Risks in Metastatic Melanoma
Alexander C.J. Van Akkooi, MD, PhD, FRACS, chair, Melanoma Surgery, Melanoma Institute Australia; associate professor, University of Sydney, discusses findings from the prospective EORTC-1208-MG registry study (NCT01942603), which, in addition to evaluating the outcomes of patients with minimal sentinel node tumor burden who were managed without complete lymph node dissection, evaluated the accuracy of local pathological review in diagnosing metastatic melanoma.